AI Terminal

MODULE: AI_ANALYST

Interactive Q&A, Risk Assessment, Summarization

MODULE: DATA_EXTRACT

Excel Export, XBRL Parsing, Table Digitization

MODULE: PEER_COMP

Sector Benchmarking, Sentiment Analysis

SYSTEM ACCESS LOCKED

Authenticate / Register Log In

Biohit Oyj

AGM Information • Sep 16, 2020

3304_rns_2020-09-16_696026c9-2284-49b4-9fe0-c0b99d8a1938.html

AGM Information

Open in Viewer

Opens in native device viewer

Disclosure 387145

Biohit Oyj - Other information disclosed according to the rules of the Exchange

Constitutive meeting of Biohit Oyj’s Board of Directors

Biohit Oyj Other information disclosed according to the rules of the Exchange September 16, 2020 at 6.00 pm local time (EET) Biohit Oyj’s Board of Directors has in its meeting today elected Mr Osmo Suovaniemi as the Chairman of the Board of Directors. Additional information: CEO Semi Korpela, Biohit Oyj tel. +358 9 773 861 [email protected] www.biohithealthcare.com Biohit in brief Biohit Oyj is a globally operating Finnish biotechnology company. Biohit’s mission is “Innovating for Health” – we produce innovative products and services to promote research and early diagnosis. Biohit is headquartered in Helsinki, Finland, and has subsidiaries in Italy and the UK. Biohit's Series B share (BIOBV) is quoted on Nasdaq Helsinki in the Small cap/Healthcare group. www.biohithealthcare.com